Latest filing published 02 Mar 2026 for Rapid Micro Biosystems, INC., €535.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Natale S. Ricciardi discloses dealings in 5 companies, chiefly Pfizer Inc, Prestige Consumer Healthcare Inc. and Mediacom Communications Corp. Between 14 March 2006 and 27 February 2026, the trades on record add up to 47 filings.
Market trades split into 3 purchases (€153k) and 5 sales (€655k). On balance, insiders were net sellers of €502k. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 31 share grants and 1 option exercise.
The median purchase comes to €44k.
The newest entry dates from 2 March 2026: an option exercise of €535, in Rapid Micro Biosystems, Inc. The last purchase on record was published on 8 February 2018, which is 3,179 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations